Concord Biotech Ltd
NSE: CONCORDBIO BSE: 543960
₹1092.30
(-0.79%)
Wed, 25 Mar 2026, 02:13 pm
Market Cap114.29B
PE Ratio36.57
Dividend0.98
Concord Biotech Cashflow
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Deprecation and amortization | -212.46M | -275.23M | -500.50M | -540.32M | -535.91M | -543.74M |
| Accumulated depreciation, total | -691.87M | -924.09M | -1.38B | -1.87B | -2.38B | -2.89B |
| Cash from operating activities | 1.54B | 1.67B | 2.09B | 2.51B | 2.67B | 2.47B |
| Funds from operations | 1.76B | 2.56B | 2.31B | 3.03B | 3.49B | 4.18B |
| Net income (cash flow) | 1.69B | 2.35B | 1.75B | 2.40B | 3.08B | 3.72B |
| Depreciation & amortization (cash flow) | 212.46M | 275.23M | 500.50M | 540.32M | 535.91M | 543.74M |
| Depreciation/depletion | 210.88M | 242.65M | 466.55M | 506.53M | 532.53M | 540.60M |
| Amortization | 1.57M | 32.58M | 33.95M | 33.79M | 3.39M | 3.14M |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | -589.69M | -847.12M | -561.27M | -727.14M | -1.18B | -1.31B |
| Changes in working capital | -218.46M | -887.67M | -220.53M | -522.86M | -811.80M | -1.71B |
| Cash from investing activities | -1.13B | -1.96B | -1.16B | -1.64B | -1.57B | -1.63B |
| Capital expenditures | -1.55B | -2.04B | -1.56B | -1.45B | -856.88M | -1.11B |
| Capital expenditures - fixed assets | -1.55B | -2.04B | -1.56B | -1.45B | -856.88M | -1.11B |
| Capital expenditures - other assets | — | — | — | — | — | — |
| Cash from financing activities | -426.37M | 315.23M | -979.38M | -846.79M | -983.97M | -986.67M |
| Free cash flow | -13.97M | -376.55M | 538.83M | 1.06B | 1.82B | 1.36B |
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800